Zille Huma (@zill_cardio) 's Twitter Profile
Zille Huma

@zill_cardio

Cardiologist | FCPS Cardioloy🩺 | FCPS IC | MRCP_UK

ID: 1373151257918062596

calendar_today20-03-2021 05:56:19

3,3K Tweet

2,2K Followers

1,1K Following

Nieves Gonzalo (@nievesgonzalo1) 's Twitter Profile Photo

Even if you have attended #EuroPCR many times, you will once again find a lot of new additions to the programme. We really hope to see you there

summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

Thank you once again to all 3,100+ attendees from 72 countries who joined us in Seoul for the 30th #TCTAP2025! Your passion and support made this milestone truly special. See you at #TCTAP2026, April 29–May 2 at COEX, Seoul! 🇰🇷💙 🔗summit-tctap.com

Thank you once again to all 3,100+ attendees from 72 countries who joined us in Seoul for the 30th #TCTAP2025! Your passion and support made this milestone truly special. See you at #TCTAP2026, April 29–May 2 at COEX, Seoul! 🇰🇷💙

đź”—summit-tctap.com
Carlos Collet MD PhD (@colletcarlos) 's Twitter Profile Photo

We are entering a new era in coronary revascularization—where predicting PCI success becomes central to clinical decision-making. Our latest view on how this shift is reshaping the field sciencedirect.com/science/articl… Hartcentrum Aalst PCRonline 🫀 TCTMD

We are entering a new era in coronary revascularization—where predicting PCI success becomes central to clinical decision-making.

Our latest view on how this shift is reshaping the field 

sciencedirect.com/science/articl…

<a href="/CardioAalst/">Hartcentrum Aalst</a> <a href="/PCRonline/">PCRonline đź«€</a> <a href="/TCTMD/">TCTMD</a>
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

You have just 🚨7 DAYS LEFT🚨 to submit your most compelling cases for #APVALVES2025! This is your chance to gain international exposure and connect with top experts in the field. Be sure to submit your cases now to put your work on the global stage! 🔗ap-valves.com/2025/case_subm…

You have just 🚨7 DAYS LEFT🚨 to submit your most compelling cases for #APVALVES2025! This is your chance to gain international exposure and connect with top experts in the field. Be sure to submit your cases now to put your work on the global stage! 

🔗ap-valves.com/2025/case_subm…
MyJSCAI (@myjscai) 's Twitter Profile Photo

🚨Simultaneous Publication presented at #SCAI2025: #TAVR shows promise for treating #aortic #regurgitation in #LVAD pts ✅ 7 high-risk pts treated ✅ 100% procedural success ✅ 86% survival at 30 days ✅ Significant symptom relief ➡️doi.org/10.1016/j.jsca… Hanad Bashir, MD

🚨Simultaneous Publication presented at #SCAI2025: #TAVR shows promise for treating #aortic #regurgitation in #LVAD pts

âś… 7 high-risk pts treated
âś… 100% procedural success
âś… 86% survival at 30 days
âś… Significant symptom relief

➡️doi.org/10.1016/j.jsca…

<a href="/HanadBashirMD/">Hanad Bashir, MD</a>
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

📢The case submission deadline for #APVALVES2025 has been extended by one more week, giving you extra time to share your most compelling and innovative work. Submit by Friday, May 16, to join this premier gathering on valvular and structural heart care! 🔗ap-valves.com/2025/case_subm…

📢The case submission deadline for #APVALVES2025 has been extended by one more week, giving you extra time to share your most compelling and innovative work. Submit by Friday, May 16, to join this premier gathering on valvular and structural heart care!
🔗ap-valves.com/2025/case_subm…
Zille Huma (@zill_cardio) 's Twitter Profile Photo

#TCTAP2025 has ended, but the learning must continue .. Wath the Vidoes_On_Demand to benefit from the academic content of the conference .. 🔗summit-tctap.com/2025/video_lis… summitmd_cvrf #VOD #CardioX

summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

Hurry! You've got only 🚨4 DAYS LEFT🚨 to submit your cases! The #APVALVES2025 submission deadline falls on this Friday, so finalize your entry today to make your voice heard in front of our global community! 🔗Case Submission Details: ap-valves.com/2025/case_subm…

Hurry! You've got only 🚨4 DAYS LEFT🚨 to submit your cases! The #APVALVES2025 submission deadline falls on this Friday, so finalize your entry today to make your voice heard in front of our global community!

🔗Case Submission Details: ap-valves.com/2025/case_subm…
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

⏰Case Submission Closes TODAY!⏰ Don't let the clock run out on your opportunity to join #APVALVES2025 as a presenter! The results will be announced in mid-late June, and we are thrilled to see you take the podium this August! 🔗ap-valves.com/2025/case_subm…

⏰Case Submission Closes TODAY!⏰

Don't let the clock run out on your opportunity to join #APVALVES2025 as a presenter! The results will be announced in mid-late June, and we are thrilled to see you take the podium this August!

🔗ap-valves.com/2025/case_subm…
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

Two must-read lecture articles from the #TCTAP2025 session "TAVR: Current Status and Future Perspective" are now online! 📖Lessons Learned from EARLY TAVR Trial 📖Current Challenges and Future Directions in Valve-in-Valve Procedures 👉Read the Articles: summit-tctap.com/2025/news_list…

Two must-read lecture articles from the #TCTAP2025 session "TAVR: Current Status and Future Perspective" are now online!

đź“–Lessons Learned from EARLY TAVR Trial
đź“–Current Challenges and Future Directions in Valve-in-Valve Procedures

👉Read the Articles: summit-tctap.com/2025/news_list…
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

📢 We've Rebranded! #SEOULVALVES2025 AP VALVES & STRUCTURAL HEART is now SEOUL VALVES! Bold new name, same trusted expertise. Join us this August as we lead the next era in structural heart care from Seoul to the world🫀 Visit Our Website Today 👉seoul-valves.com

📢 We've Rebranded! #SEOULVALVES2025

AP VALVES &amp; STRUCTURAL HEART is now SEOUL VALVES! Bold new name, same trusted expertise. 
Join us this August as we lead the next era in structural heart care from Seoul to the worldđź«€

Visit Our Website Today
👉seoul-valves.com
PCRonline đź«€ (@pcronline) 's Twitter Profile Photo

Coming out of the session "New evidence for treatment of calcified CAD" at #EuroPCR, where Alfonso Jurado-Román just presented the results of The ROLLER COASTR-EPIC22 Trial MIЯVΛƬ #IC asked him to share the key findings of this study that focuses on contemporary tool used for

Nieves Gonzalo (@nievesgonzalo1) 's Twitter Profile Photo

🔥#EuroPCR 2025 Major Late-Breaking Trials results: Angiography versus physiology-guided PCI in patients undergoing TAVI FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI,

🔥#EuroPCR 2025 Major Late-Breaking Trials results:   Angiography versus physiology-guided PCI in patients undergoing TAVI

FAITAVI is the first study comparing FFR-guided PCI with angiography-guided PCI in patients with intermediate CAD and severe symptomatic AS undergoing TAVI,
DrThomasCuisset (@cuissetdr) 's Twitter Profile Photo

#EuroPCR 2025 Major Late-Breaking Trials – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose Results of the 4D-ACS randomised trial show that, at 12-months, NACE occurred in 4.9% of the 1-month #DAPT group and 8.8% of the 12-month DAPT

#EuroPCR 2025 Major Late-Breaking Trials – One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose

Results of the 4D-ACS randomised trial show that, at 12-months, NACE occurred in 4.9% of the 1-month #DAPT group and 8.8% of the 12-month DAPT
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

✨Powered by a stellar board of leaders, the upcoming edition of #SEOULVALVES2025 is going to be your gateway to the latest breakthroughs and innovations. Join us today to connect with the world's best minds in Seoul! 🔗Early-bird Registration: seoul-valves.com/2025/attend_re…

✨Powered by a stellar board of leaders, the upcoming edition of #SEOULVALVES2025 is going to be your gateway to the latest breakthroughs and innovations. Join us today to connect with the world's best minds in Seoul! 

🔗Early-bird Registration: seoul-valves.com/2025/attend_re…
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

🆕Just released! Our latest #TCTAP2025 news article update dives into the long-term outcomes of FFR-Guided PCI vs. CABG and explores the evolving guidelines for Left Main & Multi-Vessel Revascularization in 2025. Check out the full articles now! 📰 summit-tctap.com/2025/news_list…

🆕Just released! Our latest #TCTAP2025 news article update dives into the long-term outcomes of FFR-Guided PCI vs. CABG and explores the evolving guidelines for Left Main &amp; Multi-Vessel Revascularization in 2025. 

Check out the full articles now!
📰 summit-tctap.com/2025/news_list…
summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

Relive the excitement and passion of #TCTAP2025🎇 Our 30th anniversary sketch video captures it all, from the vibrant celebrations and spark of insights. Let's keep the momentum going for #TCTAP2026, April 29-May 2, 2026💪💙 👉summit-tctap.com

summitmd_cvrf (@summitmd_cvrf) 's Twitter Profile Photo

🎊Early-bird Registration & Case Submission for #COMPLEXPCI2025 is NOW OPEN! Take part in a decade of excellence as we confront today's toughest PCI challenges and shape the next decade of progress in interventional cardiology. Visit Our Website Today 👉complex-pci.com

🎊Early-bird Registration &amp; Case Submission for #COMPLEXPCI2025 is NOW OPEN! Take part in a decade of excellence as we confront today's toughest PCI challenges and shape the next decade of progress in interventional cardiology. 

Visit Our Website Today
👉complex-pci.com